Tranilast inhibits cytokine-induced nuclear factor κB activation in vascular endothelial cells

Molecular Pharmacology

Volumn 62, Issue 4, 2002, Pages 856-863

  Spiecker, Martin ^a   Lorenz, Ioana ^b   Marx, Nikolaus ^c   Darius, Harald ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CIS ACTING ELEMENT; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYTOKINE; DNA; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; I KAPPA B ALPHA; I KAPPA B BETA; I KAPPA B EPSILON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TRANILAST; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DNA BINDING; REPORTER GENE; TRANSCRIPTION REGULATION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ACTIVATING TRANSCRIPTION FACTOR 1; ACTIVE TRANSPORT, CELL NUCLEUS; ANTHRANILIC ACIDS; CELL ADHESION MOLECULES; CELLS, CULTURED; CYTOKINES; DIMERIZATION; DNA; DNA-BINDING PROTEINS; ENDOTHELIUM, VASCULAR; HUMANS; I-KAPPA B PROTEINS; LIGASES; NF-KAPPA B; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036784118     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.62.4.856     Document Type: Article

References (37)

1. Anrather J, Csizmadia V, Soares MP, and Winkler H (1999) Regulation of NF-kappaB RelA phosphorylation and transcriptional activity by p21(ras) and protein kinase Czeta in primary endothelial cells. J Biol Chem 274:13594-13603.
2. Azuma H, Banno K, and Yoshimura T (1976) Pharmacological properties of N.(3′,4′-dimethoxycinnamoyl) anthranilic acid (N-5′), a new anti-atopic agent. Br J Pharmacol 58:483-488.
3. Beg AA and Baltimore D (1996) An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science (Wash DC) 274:782-784.
4. Brostjan C, Anrather J, Csizmadia V, Natarajan G, and Winkler H (1997) Glucocorticoids inhibit E-selectin expression by targeting NF-kappaB and not ATF/c-Jun. J Immunol 158:3836-3844.
5. Collins T, Lapierre LA, Fiers W, Strominger JL, and Pober JS (1986) Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A, B antigens in vascular endothelial cells and dermal fibroblasts in vitro. Proc Natl Acad Sci USA 83:446-450.
6. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, and Maniatis T (1995) Transcriptional regulation of endothelial cell adhesion molecules: NF- kappa B and cytokine-inducible enhancers. FASEB J 9:899-909.
7. Cybulsky MI and Gimbrone MA Jr (1991) Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science (Wash DC) 251:788-791.
8. Fukuyama J, Miyazawa K, Hamano S, and Ujiie A (1996) Inhibitory effects of tranilast on proliferation, migration and collagen synthesis of human vascular smooth muscle cells. Can J Physiol Pharmacol 74:80-84.
9. Gerritsen ME, Williams AJ, Neish AS, Moore S, Shi Y, and Collins T (1997) CREB-binding protein/p300 are transcriptional coactivators of p65. Proc Natl Acad Sci USA 94:2927-2932.
10. Isagi M, Miyata H, and Ajisawa Y (1998) Tranilast: a new application in the cardiovascular field as an antiproliferative drug. Cardiovasc Drug Rev 16:288-299.
11. Kannabiran C, Zeng X, and Vales LD (1997) The mammalian transcriptional repressor RBP (CBF1) regulates interleukin-6 gene expression. Mol Cell Biol 17:1-9.
12. Kopp E and Ghosh S (1994) Inhibition of NF-kappa B by sodium salicylate and aspirin. Science (Wash DC) 265:956-959.
13. Kosuga K, Tamai H, Ueda K, Hsu YS, Ono S, Tanaka S, Doi T, Myou UW, Motohara S, and Uehata H (1997) Effectiveness of tranilast on restenosis after directional coronary atherectomy. Am Heart J 134:712-718.
14. Marui N, Offermann MK, Swerlick R, Kunsch C, Rosen CA, Ahmad M, Alexander RW, and Medford RM (1993) Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 92:1866-1874.
15. May MJ and Ghosh S (1998) Signal transduction through NF-kappa B. Immunol Today 19:80-88.
16. Miyazawa K, Hamano S, and Ujiie A (1996) Antiproliferative and c-myc mRNA suppressive effect of tranilast on newborn human vascular smooth muscle cells in culture. Br J Pharmacol 118:915-922.
17. Miyazawa K, Kikuchi S, Fukuyama J, Hamano S, and Ujiie A (1995) Inhibition of PDGF- and TGF-beta 1-induced collagen synthesis, migration and proliferation by tranilast in vascular smooth muscle cells from spontaneously hypertensive rats. Atherosclerosis 118:213-221.
18. Naumann M and Scheidereit C (1994) Activation of NF-kappa B in vivo is regulated by multiple phosphorylations. EMBO (Eur Mol Biol Organ) J 13:4597-4607.
19. Nie L, Mogami H, Kanzaki M, Shibata H, and Kojima I (1996) Blockade of DNA synthesis induced by platelet-derived growth factor by tranilast, an inhibitor of calcium entry, in vascular smooth muscle cells. Mol Pharmacol 50:763-769.
20. Peng HB, Rajavashisth TB, Libby P, and Liao JK (1995) Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells. J Biol Chem 270:17050-17055.
21. Saiura A, Sata M, Hirata Y, Nagai R, and Makuuchi M (2001) Tranilast inhibits transplant-associated coronary arteriosclerosis in a murine model of cardiac transplantation. Eur J Pharmacol 433:163-168.
22. Shiota N, Okunishi H, Takai S, Mikoshiba I, Sakonjo H, Shibata N, and Miyazaki M (1999) Tranilast suppresses vascular chymase expression and neointima formation in balloon-injured dog carotid artery. Circulation 99:1084-1090.
23. Soares MP, Muniappan A, Kaczmarek E, Koziak K, Wrighton CJ, Steinhauslin F, Ferran C, Winkler H, Bach FH, and Anrather J (1998) Adenovirus-mediated expression of a dominant negative mutant of p65/RelA inhibits proinflammatory gene expression in endothelial cells without sensitizing to apoptosis. J Immunol 161:4572-4582.
24. SoRelle R (2001) Late-breaking clinical trials at the American Heart Association's scientific sessions 2001. Circulation 104:E9046-E9048.
25. Spiecker M, Darius H, Kaboth K, Hubner F, and Liao JK (1998) Differential regulation of endothelial cell adhesion molecule expression by nitric oxide donors and antioxidants. J Leukoc Biol 63:732-739.
26. Spiecker M, Darius H, and Liao JK (2000) A functional role of IkappaB-epsilon in endothelial cell activation. J Immunol 164:3316-3322.
27. Spiecker M, Peng HB, and Liao JK (1997) Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IkappaBalpha. J Biol Chem 272:30969-30974.
28. Springer TA (1990) Adhesion receptors of the immune system. Nature (Lond) 346:425-434.
29. Suzawa H, Kikuchi S, Arai N, and Koda A (1992) The mechanism involved in the inhibitory action of tranilast on collagen biosynthesis of keloid fibroblasts. Jpn J Pharmacol 60:91-96.
30. Tamai H, Katoh O, Suzuki S, Fujii K, Aizawa T, Takase S, Kurogane H, Nishikawa H, Sone T, Sakai K, et al. (1999) Impact of tranilast on restenosis after coronary angioplasty: tranilast restenosis following angioplasty trial (TREAT). Am Heart J 138:968-975.
31. Tanaka K, Honda M, Kuramochi T, and Morioka S (1994) Prominent inhibitory effects of tranilast on migration and proliferation of and collagen synthesis by vascular smooth muscle cells. Atherosclerosis 107:179-185.
32. Traenckner EB, Wilk S, and Baeuerle PA (1994) A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B. EMBO (Eur Mol Biol Organ) J 13:5433-5441.
33. Vanden Berghe W, Plaisance S, Boone E, De Bosscher K, Schmitz ML, Fiers W, and Haegeman G (1998) p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor. J Biol Chem 273:3285-3290.
34. Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, and Miyamoto S (1995) Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev 9:2723-2735.
35. Vo N and Goodman H (2001) CREB-binding protein and p300 in transcriptional regulation. J Biol Chem 276:13505-13508.
36. Wang CY, Mayo MW, and Baldwin AS Jr (1996) TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science (Wash DC) 274:784-787.
37. Zhong H, SuYang H, Erdjument-Bromage H, Tempst P, and Ghosh S (1997) The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 89:413-424.